Mayumi Shikano

5PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Paediatrics not elsewhere classifiedRecommender systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 19, 2026
Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA/EMA.

|Sep 12, 2025
Accelerating clinical development outside the usual regions for future pandemics: a comparative analysis of COVID-19 therapeutic development between the USA and Japan.

Miyuki Katayama, Mayumi Shikano

|Apr 13, 2025
Clinical data required for the approval of pediatric pharmaceuticals in Japan.

Hisamitsu Haigo, Kenji Matsuda, Mayumi Shikano

|Oct 11, 2023
Implementation status and consideration for the globalisation of decentralised clinical trials: a cross-sectional analysis of clinical trial databases.

Takahiro Sato, Shota Mizumoto, Midori Ota

|Jul 19, 2022
Impact of the Clinical Trials Act 2018 on clinical trial activity in Japan from 2018 to 2020: a retrospective database study using new and conventional Japanese registries.

Hiroyuki Taruno, Mari S Oba, Osamu Takizawa

Pageof 1

Frequent Collaborators

1 joint publications

Hiroyuki Taruno

1 joint publications

Mari S Oba

1 joint publications

Takahiro Sato

1 joint publications

Hisamitsu Haigo